Lipid mediators control macrophage and fibroblast phenotype, and support regeneration in the alveolar niche
Macrophage-derived lipid mediators play pivotal autocrine/paracrine roles in resolution and repair. In the alveolar niche, “regenerative fibroblasts” produce vital growth factors (FGF7/10) for alveolar stem cells to regenerate damaged epithelia, however the signals controlling fibroblast phenotype are yet to be defined. <bold>Aim:</bold> To investigate the role of macrophage-derived PGE<sub>2</sub>, specialized pro-resolving mediators (SPMs) and growth factors in controlling interstitial fibroblast phenotype during regeneration of alveolar injury. IPF myofibroblasts were treated with PGE<sub>2</sub> and studied by RNAseq. IPF BAL macrophages were treated with PGE<sub>2</sub> and analysed in a fibrosis and resolution-focused QuantiGene assay. Further, to investigate the regenerative potential of lipid mediators in the macrophage-fibroblast-epithelial cell axis, we are developing 3D co-culture systems integrating macrophage signals, fibroblasts and lung progenitors. <bold>Results:</bold> PGE<sub>2</sub> reverted myofibroblast phenotype, re-activated expression of FGF7/10, and upregulated markers of lipofibroblasts and matrix fibroblasts (TCF21 and COL14A1), while reducing myofibroblast genes (ACTA2, COL1A1 and SERPINE1) and genes involved in the Serine - Glycine synthesis pathway (PHGDH, PSAT1, PSPH and SHMT2). Similarly, PGE<sub>2</sub> inhibited pro-fibrotic signals such as SERPINE1 and CCL24 from IPF BAL macrophages and enhanced expression of THBS1, AREG and VEGFA known to increase efferocytotic capacity, drive fibroblasts FGF7/10 and to support vascular regeneration, respectively. Our data support a model where macrophage signals controlling fibroblast phenotype have the potential to restrict fibrosis in IPF and activate regeneration of the alveolar niche.
Authors
- Kristin Wiqvist
- Toby M. Maher (ORCID: https://orcid.org/0000-0001-7192-9149)
- Philip L. Molyneaux (ORCID: https://orcid.org/0000-0003-1301-8800)
- Melker Göransson (ORCID: https://orcid.org/0000-0002-8859-6915)
- Catherine Overed-Sayer (ORCID: https://orcid.org/0000-0001-7301-2633)
Institutions
- AstraZeneca (Netherlands) (NL)
- AstraZeneca (Singapore) (SG)
- Imperial College London (GB)
Publication Details
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1183/23120541.lsc-2025.tp118
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00